Compliance to intensive multiweek radiation therapy (RT) regimens in head and neck cancer (HNC) patients is challenging, particularly among medically underserved patients with fewer financial and social resources. Treatment prolongation reduces local control and overall survival rates, making adherence to treatment a key factor in optimal outcome. We evaluated factors affecting compliance in medically underserved patients who received RT for HNC in a large municipal hospital setting in New York City.

Study Design:

Retrospective review.

Methods:

Treatment records of patients treated between July 2004 and August 2008 were reviewed. Number of and reasons for missed treatments were identified. Several demographic, toxicity, and treatment variables were analyzed for impact on compliance.

Results:

Eighty consecutive HNC patients who underwent RT with a 5- to 7-week regimen were identified. Thirty-two patients (40%) missed no treatments, 36 (45%) missed one to six treatments, six (8%) missed seven to 14 treatments, two (3%) missed more than 14 treatments, and four (5%) did not complete treatment. Reasons for missed treatments were hospitalization (31% of events) and toxicity (20%). Patients with percutaneous endoscopic gastrostomy tube were more likely to miss treatments (P = .01, χ² test). No other variable showed a significant association with missed treatments (χ² test).

Conclusions:

Intensive RT for HNC can be delivered with very good adherence within a medically underserved population. Eighty-five percent of patients completed treatment with 0 to 6 days of interruption. Efforts to further improve adherence in this population are ongoing. Laryngoscope, 2010

BIBLIOGRAPHY

1 Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008; 371: 1695–1709.
10.1016/S0140-6736(08)60728-X
CAS PubMed Web of Science® Google Scholar
2 Bese NS, Hendry J, Jeremic B. Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 2007; 68: 654–661.
10.1016/j.ijrobp.2007.03.010
PubMed Web of Science® Google Scholar
3 Suwinski R, Sowa A, Rutkowski T, Wydmanski J, Tarnawski R, Maciejewski B. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 2003; 56: 399–412.
10.1016/S0360-3016(02)04469-3
PubMed Web of Science® Google Scholar
4 Pajak TF, Laramore GE, Marcial VA, et al. Elapsed treatment days—a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 1991; 20: 13–20.
10.1016/0360-3016(91)90132-N
CAS PubMed Web of Science® Google Scholar
5 Hendry JH, Bentzen SM, Dale RG, et al. A modeled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol 1996; 8: 297–307.
10.1016/S0936-6555(05)80715-0
CAS PubMed Google Scholar
6 Robertson C, Robertson AG, Hendry JH, et al. Similar decreases in local tumor control are calculated for treatment protraction and interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 1998; 40: 319–329.
10.1016/S0360-3016(97)00716-5
CAS PubMed Web of Science® Google Scholar
7 Patel UA, Thakakar KH, Holloway N. Patient compliance to radiation for advanced head and neck cancer patients at a tertiary care county hospital. Laryngoscope 2008; 118: 428–432.
10.1097/MLG.0b013e31815ae3d2
PubMed Web of Science® Google Scholar
8Health Resources and Services Administration Web site. U.S. Department of Health and Human Services. Available at: http://bhpr.hrsa.gov. Accessed February 15, 2010.
Google Scholar
9New York City Health and Hospitals Corporation Web site. Available at: http://www.nyc.gov/html/hhc. Accessed February 15, 2010.
Google Scholar
10 Ban den Bogaert W, Van der Leest A, Rijnders A, Delaere P, Thames H, van der Schuerren E. Does tumor control decrease by prolonging overall treatment time or interrupting treatment in laryngeal cancer? Radiother Oncol 1995; 36: 177–182.
10.1016/0167-8140(95)01597-A
PubMed Web of Science® Google Scholar
11 Maciejewski B, Withers HR, Taylor JM, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys 1989; 16: 831–843.
10.1016/0360-3016(89)90503-8
CAS PubMed Web of Science® Google Scholar
12 Maciejewski B, Preuss-Bayer G, Trott KR. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983; 9: 321–328.
10.1016/0360-3016(83)90290-0
CAS PubMed Web of Science® Google Scholar
13 Wang CC. Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes. Int J Radiat Oncol Biol Phys 1988; 14; 1143–1146.
10.1016/0360-3016(88)90390-2
CAS PubMed Web of Science® Google Scholar
14 Bataini JP, Asselain B, Jaulerry C, et al. A multivariate primary tumour control analysis in 465 patients treated by radical radiotherapy for cancer of the tonsillar region: clinical and treatment parameters as prognostic factors. Radiother Oncol 1989; 14: 265–277.
10.1016/0167-8140(89)90138-2
CAS PubMed Web of Science® Google Scholar
15 Mendenhall WM, Parsons JT, Stringer SP, et al. The T2 oral tongue carcinoma treated with radiotherapy: analysis of local control and complications. Radiother Oncol 1989; 16: 275–281.
10.1016/0167-8140(89)90039-X
CAS PubMed Web of Science® Google Scholar
16 Taylor JMG, Withers HR, Mendenhall WM. Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother Oncol 1990; 17: 95–102.
10.1016/0167-8140(90)90096-F
CAS PubMed Web of Science® Google Scholar
17 Hoekstra CJM, Levendag PC, van Putten LJ. Squamous cell carcinoma of the supraglottic larynx without clinically detectable lymph node metastases: problem of local relapse and influence of overall treatment time. Int J Radiat Oncol Biol Phys 1990; 18: 13–21.
10.1016/0360-3016(90)90261-H
CAS PubMed Web of Science® Google Scholar
18 Barton MB, Keane TJ, Galla T, et al. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 24: 137–143.
10.1016/0167-8140(92)90323-M
PubMed Web of Science® Google Scholar
19 Robertson AG, Robertson C, Boyle P, et al. The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. Eur J Cancer 1993; 4: 501–510.
10.1016/S0959-8049(05)80139-X
Web of Science® Google Scholar
20 Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–146.
10.3109/02841868809090333
CAS PubMed Web of Science® Google Scholar
21 Tarnawski R, Fowler J, Skladowski K, et al. How fast is repopulation of tumor cells during the treatment gap? Int J Radiat Oncol Biol Phys 2002; 54: 229–236.
10.1016/S0360-3016(02)02936-X
PubMed Web of Science® Google Scholar
22 Khalil AA, Bentzen SM, Bernier J, et al. Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Int J Radiat Oncol Biol Phys 2003; 55: 568–575.
10.1016/S0360-3016(02)03790-2
PubMed Web of Science® Google Scholar
23 Fesinmeyer MD, Mehta V, Tock L, Blough D, McDermott C, Ramsey SD. Completion of radiotherapy for local and regional head and neck cancer in Medicare. Arch Otolaryngol Head Neck Surg 2009; 135: 860–867.
10.1001/archoto.2009.108
PubMed Web of Science® Google Scholar

Citing Literature

Volume120, Issue7

July 2010

Pages 1336-1341

Head and neck radiotherapy compliance in an underserved patient population^†

Abstract

Objectives/Hypothesis:

Study Design:

Methods:

Results:

Conclusions:

BIBLIOGRAPHY

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Head and neck radiotherapy compliance in an underserved patient population†

Abstract

Objectives/Hypothesis:

Study Design:

Methods:

Results:

Conclusions:

BIBLIOGRAPHY

Citing Literature

References

Related

Information

Head and neck radiotherapy compliance in an underserved patient population^†